Safety and efficacy of apatinib as third or later line treatment for advanced gastric cancer or gastroesophageal junction adenocarcinoma: A post-marketing phase IV study.

doi:10.1200/JCO.2021.39.15_suppl.e16034

	Safety and efficacy of apatinib as third or later line treatment for advanced gastric cancer or gastroesophageal junction adenocarcinoma: A post-marketing phase IV study.
	Li, Jin ; Qin, Shukui ; Wen, Lu ; Wang, Junsheng ; Deng, Wenying ; Guo, Weijian ; Jia, Tongfu ; Jiang, Da ; Zhang, Guifang ; He, Yifu
刊名	JOURNAL OF CLINICAL ONCOLOGY
	2021-05-20
卷号	39
ISSN号	0732-183X
DOI	10.1200/JCO.2021.39.15_suppl.e16034
资助项目	Jiangsu Hengrui Pharmaceuticals Co., Ltd
WOS研究方向	Oncology
语种	英语
出版者	LIPPINCOTT WILLIAMS & WILKINS
WOS记录号	WOS:000708120301308
资助机构	Jiangsu Hengrui Pharmaceuticals Co., Ltd
内容类型	期刊论文
源URL	[http://ir.hfcas.ac.cn:8080/handle/334002/126672]
专题	中国科学院合肥物质科学研究院
作者单位	1.Hebei Med Univ, Dept Oncol, Hosp 4, Shijiazhuang, Hebei, Peoples R China 2.Jiangsu Hengrui Pharmaceut Co Ltd, Shanghai, Peoples R China 3.Heilongjiang Agr Reclamat Bur Gen Hosp, Harbin, Peoples R China 4.Sun Yat Sen Univ, Affiliated Hosp 3, Dept Oncol, Guangzhou, Peoples R China 5.Harbin Med Univ Canc Hosp, Dept Oncol, Harbin, Peoples R China 6.Changzhi Peoples Hosp, Dept Oncol, Changzhi, Peoples R China 7.Fujian Med Univ Canc Hosp, Fujian Canc Hosp, Dept Abdominal Oncol, Fuzhou, Peoples R China 8.Fujian Med Univ, Dept Med Oncol, Affiliated Union Hosp, Fuzhou, Peoples R China 9.Tianjin Med Univ Canc Inst & Hosp, Dept Gastrointestinal Med Oncol, Key Lab Canc Prevent & Therapy, Tianjins Clin Res Ctr Canc,Natl Clin Res Ctr Canc, Tianjin, Peoples R China 10.Univ Chinese Acad Sci, Chinese Acad Sci, Inst Canc & Basic Med, Dept Med Oncol,Zhejiang Canc Hosp,Canc Hosp, Hangzhou, Peoples R China
推荐引用方式 GB/T 7714	Li, Jin,Qin, Shukui,Wen, Lu,et al. Safety and efficacy of apatinib as third or later line treatment for advanced gastric cancer or gastroesophageal junction adenocarcinoma: A post-marketing phase IV study.[J]. JOURNAL OF CLINICAL ONCOLOGY,2021,39.
APA	Li, Jin.,Qin, Shukui.,Wen, Lu.,Wang, Junsheng.,Deng, Wenying.,...&Hou, Zhiguo.(2021).Safety and efficacy of apatinib as third or later line treatment for advanced gastric cancer or gastroesophageal junction adenocarcinoma: A post-marketing phase IV study..JOURNAL OF CLINICAL ONCOLOGY,39.
MLA	Li, Jin,et al."Safety and efficacy of apatinib as third or later line treatment for advanced gastric cancer or gastroesophageal junction adenocarcinoma: A post-marketing phase IV study.".JOURNAL OF CLINICAL ONCOLOGY 39(2021).